HNN3.0
Register
Register
Register

Project cooperationUpdated on 22 January 2026

Trust4Life: Sovereign Infrastructure Pilot (TRL 6) for Biobanking & EHDS

CEO & Founder at Trustvestor Ltd.

Varna, Bulgaria

About

Trustvestor Ltd. (SME, NL/BG) is a QTSP-candidate under eIDAS 2.0. We are building the sovereign validation layer specifically for the Health Data Space (EHDS).

We are looking to join a BrainHealth Consortium as a Technology Validation Partner (TRL 6). We offer our infrastructure as an "Industrial Testbed" to demonstrate secure chain-of-custody for sensitive data.

Our USP (The Innovation we bring):

1. Sovereignty: We utilize Local EU Hardware Security Modules (HSMs) to prototype a storage environment immune to US Cloud Act risks [Source: Internal Strategy].

2. Compliance-as-Code: We are developing Trust4Life – a module designed to issue Qualified Electronic Attestations (QEAA) for dynamic patient consent.

3. Readiness: We have the architectural prototype (based on NGI Zero/Solid) and need a clinical partner to validate it in an operational environment (moving from TRL 5 to TRL 7).

Target Partners:

• Coordinators of EP BrainHealth Calls looking for a strong Data Privacy / Sovereignty Work Package.

• Biobanks willing to run a pilot on sovereign data provenance.

Topic

  • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
  • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies

Type

  • Partner seeks Consortium/Coordinator

Organisation

Trustvestor Ltd.

Company (SME)

Varna, Bulgaria

Similar opportunities

  • Project cooperation

    Translational Evidence Framework for Human-Relevant NAM Validation

    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

    Emilien Nicolas

    R&D Preclinical manager at CER Groupe

    Aye, Belgium

  • Project cooperation

    FAIR & EHDS-Aligned Data Infrastructures for Health Research and Innovation

    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

    Theo Zacharis

    Executive Director / Founder at Kinesis Innovation Center

    Athens, Greece

  • Project cooperation

    Investment and co-development partners for a buccal drug delivery platform (TRL 5 → TRL 6)

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

    David Molinero Caravantes

    CEO at MEDICAL FLOWERS DEVELOPMENTS

    MADRID, Spain